.png)
.png)
Latest news from BIA
BIA welcomes new £2.5bn fund for innovative UK businesses
The BIA welcomes the creation of British Patient Capital, a £2.5 billion fund launched today by the British Business Bank. The fund will provide long-term funding to support the growth of innovative UK bioscience companies and other sectors.
New Industrial Biotechnology Strategy launched to secure UK leadership in clean growth
Today the Industrial Biotechnology Leadership Forum (IBLF) launches the new ‘National Industrial Biotechnology Strategy to 2030’, promoted in partnership with the UK BioIndustry Association (BIA). The Strategy has been developed by the IBLF and two collaborative networks in industrial biotech, CBMNet and BIOCATNET.
BIA comment on Government response to the Health Committee’s report on Brexit and medicines, medical devices and substances of human origin
The BIA has commented on the Government’s response to the Health Committee’s report on Brexit and medicines, medical devices and substances of human origin.
Life Sciences sector responds to the Business, Energy and Industrial Strategy (BEIS) Committee report on the impact of Brexit on the pharmaceutical sector
A report published today [Thursday 17 May] by the BEIS Strategy Committee, calls on the Government to secure a post-Brexit deal to protect the patients in the UK and the UK's pharmaceutical industry.
Microbiotica Collaborates with University of Adelaide to Develop a Novel Microbial Therapy for Ulcerative Colitis
Cambridge, UK, 18 June 2018 – Microbiotica, a leading player in microbiome-based therapeutics, today announced that it has entered into an agreement with University of Adelaide as part of its programme to develop a defined bacterial product for ulcerative colitis (UC). Financial details have not been disclosed.
MedAnnex Ltd Receives SMART: SCOTLAND R&D Award
Scottish Enterprise will contribute up to £423,000 towards the industrial development of a novel antibody to treat autoimmune diseases
NetScientific portfolio company Vortex Biosciences appoints new chief executive officer
NetScientific said Bob Englert, who is currently chief technology officer, takes up the position with immediate effect, replacing Gene Walther
Microbiotica Enters into Microbiome Collaboration with Genentech
• Strategic collaboration for microbiome biomarker signatures and therapeutic discovery based on Genentech’s inflammatory bowel disease pipeline • Utilises Microbiotica’s leading gut microbiome Reference Genome Database and Culture Collection • Microbiotica to receive up to $534 million in upfront and milestone payments
CEO Update: Monday 18 June
Last week we saw some great news for our sector. The £2.5 billion British Patient Capital fund, launched by the British Business Bank, will provide long-term funding to support the growth of innovative UK bioscience companies and other sectors and will help to build the next generation of UK life science companies to scale to global leadership.
Video of the week: Opportunities for UK Life Sciences companies in China
Find out how the business and regulatory environment is changing, and hear from Department for International Trade experts based in China, from UK Life Sciences companies who have invested there and from organisations in China who can help with advice and incubation services.
CEO Update: Monday 11 June
Last week, the BIA was out in Boston for BIO 2018. UK companies became Official World record holders, showcasing UK excellence, and partnering and engaging with the international biotech community.
A strategy for clean growth: the potential of industrial biotech
The following guest blog is from Dr Jen Vanderhoven, Senior Project Manager for FUJIFILM Diosynth Biotechnologies, and Dr Mark Corbett, Network Manager for BIOCATNET, a BBSRC Network in Industrial Biotechnology and Bioenergy.
Please find a selection of featured BIA publications below. To see our full publications library, click here.
Influencing and shaping our sector, BIA update: January - April 2018
This quarterly update gives an overview of key policy developments and the BIA’s continued engagement with policymakers, regulatory authorities and wider stakeholders on behalf of the UK life sciences industry, from January to April 2018.
Biotech Financing Update: December 2017 to February 2018
The BIA/Informa Biotech Financing Update: December 2017-February 2018 released today shows that venture capital financing and follow on financing on the public markets are off to a solid start in 2018.
Pipeline Progressing: The UK's Global Bioscience Cluster in 2017
A new report released by the BioIndustry Association (BIA) and Informa Pharma Intelligence reveals that the UK has the strongest clinical and preclinical pipeline in Europe.
BIA Best practice guide for communicating R&D
Ensuring investors and the wider public are well informed and confident about bioscience is crucial to the success of individual companies and the sector as a whole. To support the sector to maintain high standards in communications about R&D progress, the BIA has produced a best practice guide for bioscience companies with a supporting library of resources.
